Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NYHA Class II-IV Heart Failure”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableStudy completedNCT04218435
What this trial is testing

Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients

Who this might be right for
Heart Failure NYHA Class IVHeart Failure NYHA Class II
Clinision 200
Not applicableActive Not RecruitingNCT06270875
What this trial is testing

Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)

Who this might be right for
Chronic IllnessNYHA Class II-IV Heart Failure
University of Alabama at Birmingham 10
Not applicableStudy completedNCT04180696
What this trial is testing

Mid-Q Response Study

Who this might be right for
Heart FailureLeft Bundle-Branch BlockHeart Failure With Reduced Ejection Fraction (HFrEF)+3 more
Medtronic Cardiac Rhythm and Heart Failure 177
Not applicableStudy completedNCT01452802
What this trial is testing

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

Who this might be right for
Heart Failure
Abbott Medical Devices 200
Large-scale testing (Phase 3)Study completedNCT00853658
What this trial is testing

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 7,064
Post-approval studies (Phase 4)Ended earlyNCT03026088
What this trial is testing

Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants

Who this might be right for
Heart Failure
Merck KGaA, Darmstadt, Germany 20
Large-scale testing (Phase 3)Ended earlyNCT03909295
What this trial is testing

An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Novartis Pharmaceuticals 52
Not applicableLooking for participantsNCT07045649
What this trial is testing

Association Between the Sit-To-Stand Test and the Prognosis of Patients With Heart Failure

Who this might be right for
Heart FailureHeart Failure NYHA Class IVHeart Failure; With Decompensation+2 more
Centro Universitário Augusto Motta 68
Not applicableStudy completedNCT03388918
What this trial is testing

Future Patient - Telerehabilitation of Heart Failure Patients

Who this might be right for
Heart Failure NYHA Class IHeart Failure NYHA Class IIHeart Failure NYHA Class III+2 more
Aalborg University 140
Not applicableStudy completedNCT06233695
What this trial is testing

Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure NYHA Class II+2 more
Alexandria University 100
Testing effectiveness (Phase 2)UnknownNCT05336175
What this trial is testing

Biomarker Study: Heart Failure Patients at Risk

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class IV
University of Arizona 40
Not applicableUnknownNCT05487365
What this trial is testing

Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF

Who this might be right for
Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class III+1 more
Comunicare Solutions SA 330
Not applicableStudy completedNCT03387813
What this trial is testing

Hemodynamic-GUIDEd Management of Heart Failure

Who this might be right for
Heart FailureHeart Failure, SystolicHeart Failure, Diastolic+7 more
Abbott Medical Devices 2,358
Testing effectiveness (Phase 2)Study completedNCT01814319
What this trial is testing

Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure

Who this might be right for
Systolic Heart Failure
University of Cincinnati 20
Post-approval studies (Phase 4)UnknownNCT01040494
What this trial is testing

Add-on Aliskiren Treatment in Patients With Chronic Congestive Heart Failure

Who this might be right for
Congestive Heart Failure
National Taiwan University Hospital 60
Not applicableUnknownNCT01669395
What this trial is testing

Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial

Who this might be right for
Chronic Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class III+1 more
University Hospital, Gentofte, Copenhagen 80
Large-scale testing (Phase 3)Study completedNCT00007683
What this trial is testing

Warfarin and Antiplatelet Therapy in Chronic Heart Failure

Who this might be right for
Heart Failure
US Department of Veterans Affairs 1,587
Not applicableLooking for participantsNCT05632432
What this trial is testing

Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery

Who this might be right for
Ischemic Heart DiseaseIschemic CardiomyopathyHeart Failure, Systolic+4 more
Hospital District of Helsinki and Uusimaa 50
Not applicableStudy completedNCT05236673
What this trial is testing

Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure

Who this might be right for
Heart Failure
Boehringer Ingelheim 610
Not applicableWithdrawnNCT03947853
What this trial is testing

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure

Who this might be right for
Heart FailureHeart Failure NYHA Class IIIHeart Failure NYHA Class II+1 more
Elpen Pharmaceutical Co. Inc.
Load More Results